Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
暂无分享,去创建一个
[1] G. Chang-Chien,et al. Sodium Butyrate Modulates Blood Pressure and Gut Microbiota in Maternal Tryptophan-Free Diet-induced Hypertension Rat Offspring. , 2022, The Journal of nutritional biochemistry.
[2] S. Clare,et al. Identification of gut microbial species linked with disease variability in a widely used mouse model of colitis , 2022, Nature Microbiology.
[3] Chi-I Chang,et al. Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut–Kidney Axis , 2021, Antioxidants.
[4] Y. Tain,et al. Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension , 2021, Frontiers in Endocrinology.
[5] Chi-I Chang,et al. Perinatal Resveratrol Therapy to Dioxin-Exposed Dams Prevents the Programming of Hypertension in Adult Rat Offspring , 2021, Antioxidants.
[6] Y. Tain,et al. Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins , 2021, International journal of molecular sciences.
[7] Chien-Te Lee,et al. Maternal Resveratrol Therapy Protected Adult Rat Offspring against Hypertension Programmed by Combined Exposures to Asymmetric Dimethylarginine and Trimethylamine-N-oxide: Resveratrol and gut microbiota in programmed hypertension. , 2021, The Journal of nutritional biochemistry.
[8] Y. Tain,et al. Synthesis of Short-Chain-Fatty-Acid Resveratrol Esters and Their Antioxidant Properties , 2021, Antioxidants.
[9] J. Chan,et al. Altered Gut Microbiota and Its Metabolites in Hypertension of Developmental Origins: Exploring Differences between Fructose and Antibiotics Exposure , 2021, International journal of molecular sciences.
[10] G. Chang-Chien,et al. Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites , 2020, Biomedicines.
[11] Y. Tain,et al. Synthesis and Characterization of Novel Resveratrol Butyrate Esters That Have the Ability to Prevent Fat Accumulation in a Liver Cell Culture Model , 2020, Molecules.
[12] Hailing Shao,et al. The Endocrine Disruption of Prenatal Phthalate Exposure in Mother and Offspring , 2020, Frontiers in Public Health.
[13] M. Reale,et al. Critical Review on the Presence of Phthalates in Food and Evidence of Their Biological Impact , 2020, International journal of environmental research and public health.
[14] E. Cairrão,et al. Phthalates Implications in the Cardiovascular System , 2020, Journal of cardiovascular development and disease.
[15] Yi Zhao,et al. Aryl Hydrocarbon Receptor as a target for lycopene preventing DEHP-induced spermatogenic disorders. , 2020, Journal of agricultural and food chemistry.
[16] Y. Tain,et al. Maternal Exposure to Bisphenol A Combined with High-Fat Diet-Induced Programmed Hypertension in Adult Male Rat Offspring: Effects of Resveratrol , 2019, International journal of molecular sciences.
[17] Francesco Asnicar,et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.
[18] Subash C. Gupta,et al. Health benefits of resveratrol: Evidence from clinical studies , 2019, Medicinal research reviews.
[19] R. S. Bhaskaran,et al. Developmental exposure to DEHP alters hepatic glucose uptake and transcriptional regulation of GLUT2 in rat male offspring. , 2019, Toxicology.
[20] J. Mercader,et al. Resveratrol, Metabolic Syndrome, and Gut Microbiota , 2018, Nutrients.
[21] Y. Tain,et al. Maternal Resveratrol Therapy Protects Male Rat Offspring against Programmed Hypertension Induced by TCDD and Dexamethasone Exposures: Is It Relevant to Aryl Hydrocarbon Receptor? , 2018, International journal of molecular sciences.
[22] F. Altieri,et al. Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans , 2017, Oxidative medicine and cellular longevity.
[23] U. Förstermann,et al. Antioxidant effects of resveratrol in the cardiovascular system , 2017, British journal of pharmacology.
[24] J. Pluznick. Microbial Short-Chain Fatty Acids and Blood Pressure Regulation , 2017, Current Hypertension Reports.
[25] U. Das,et al. Beneficial action of resveratrol: How and why? , 2016, Nutrition.
[26] S. Shyue,et al. Maternal exposure to di-(2-ethylhexyl) phthalate exposure deregulates blood pressure, adiposity, cholesterol metabolism and social interaction in mouse offspring , 2016, Archives of Toxicology.
[27] J. Dyck,et al. Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol , 2014, Front. Physiol..
[28] X. Chen,et al. Maternal exposure to di-(2-ethylhexyl)phthalate alters kidney development through the renin-angiotensin system in offspring. , 2012, Toxicology letters.
[29] Peter Gluckman,et al. Developmental origins of noncommunicable disease: population and public health implications. , 2011, The American journal of clinical nutrition.
[30] M. Usami,et al. Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. , 2011, Clinical nutrition.
[31] T. Walle. Bioavailability of resveratrol , 2011, Annals of the New York Academy of Sciences.
[32] K. Sonoyama. Metabolic syndrome and gut microbiota. , 2010 .
[33] L. Lavis. Ester bonds in prodrugs. , 2008, ACS chemical biology.
[34] A. Nynca,et al. Effects of Acute and Chronic Exposure to the Aryl Hydrocarbon Receptor Agonist 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the Transition to Reproductive Senescence in Female Sprague-Dawley Rats1 , 2006, Biology of reproduction.
[35] J F Reckelhoff,et al. Gender Differences in the Regulation of Blood Pressure , 2001, Hypertension.
[36] Ian L. Rogers,et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. , 1999, Molecular pharmacology.